Literature DB >> 3944707

Liver cirrhosis associated with chronic hepatitis B virus infection in childhood.

F Bortolotti, R Calzia, P Cadrobbi, R Giacchini, B Ciravegna, M Armigliato, R Piscopo, G Realdi.   

Abstract

We evaluated the prevalence and the clinical features of liver cirrhosis associated with chronic hepatitis B virus (HBV) infection in a prospective study of 292 consecutive children who were chronic HBsAg carriers with increased aminotransferase activity. Liver histologic changes at presentation were consistent with cirrhosis in 10 (3.4%) patients (100% boys, mean age 4.0 +/- 3.3 years). In none of the remaining children, including 166 with histologic evidence of chronic active hepatitis, did the condition progress to cirrhosis during an observation period of 1 to 10 years. This lack of progression suggests that cirrhosis is an early complication of chronic HBV disease in some patients. A higher prevalence of delta infection and increased incidence of blood transfusions were observed in patients with cirrhosis, supporting the hypothesis that superinfection with delta or non-A, non-B agents may play a synergistic role. Eight of 10 patients had histologic features of disease activity at presentation, although only two had symptoms. During follow-up, persistence of disease activity was observed only in the three delta antigen-positive patients. None of the patients with inactive cirrhosis have developed signs of liver failure or portal hypertension.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944707     DOI: 10.1016/s0022-3476(86)80987-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

1.  Lamivudine therapy for children with chronic hepatitis B.

Authors:  Anna Liberek; Anna Szaflarska-Popławska; Maria Korzon; Grazyna Łuczak; Magdalena Góra-Gebka; Ewa Łoś-Rycharska; Wanda Bako; Mieczysława Czerwionka-Szaflarska
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

2.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

3.  Serological and histological follow up of chronic hepatitis B infection.

Authors:  M Ruiz-Moreno; T Camps; J G Aguado; J C Porres; H Oliva; J Bartolomé; V Carreño
Journal:  Arch Dis Child       Date:  1989-08       Impact factor: 3.791

4.  Combination of Entecavir/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune Tolerant Chronic Hepatitis B Virus Infection.

Authors:  Philip Rosenthal; Simon C Ling; Steven H Belle; Karen F Murray; Norberto Rodriguez-Baez; Sarah J Schwarzenberg; Jeffrey Teckman; Hsing-Hua S Lin; Kathleen B Schwarz
Journal:  Hepatology       Date:  2019-02-20       Impact factor: 17.425

Review 5.  Viral hepatitis.

Authors:  G V Gregorio; G Mieli-Vergani; A P Mowat
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

6.  Natural history and clinical management of chronic hepatitis B virus infection in children.

Authors:  Mei-Hwei Chang
Journal:  Hepatol Int       Date:  2008-03-06       Impact factor: 6.047

7.  Chronic non-A, non-B hepatitis: role of hepatitis C virus.

Authors:  R Iorio; S Guida; S Porzio; I Fariello; A Vegnente
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

8.  Natural history of hepatitis B in perinatally infected carriers.

Authors:  E H Boxall; J Sira; R A Standish; P Davies; E Sleight; A P Dhillon; P J Scheuer; D A Kelly
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

9.  IgM antibody to hepatitis B core antigen in children with chronic type B hepatitis.

Authors:  F Bortolotti; A Bertaggia; L Rude; M Armigliato; C Crivellaro; A Alberti; E Pornaro; G Realdi
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

10.  Children with Chronic Hepatitis B in the United States and Canada.

Authors:  Kathleen B Schwarz; Yona Keich Cloonan; Simon C Ling; Karen F Murray; Norberto Rodriguez-Baez; Sarah Jane Schwarzenberg; Jeffrey Teckman; Lilia Ganova-Raeva; Philip Rosenthal
Journal:  J Pediatr       Date:  2015-09-10       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.